Amgen has potential to compete with established leaders in obesity drugs
On January 8, Amgen presented at JP Morgan’s 42nd Annual Healthcare Conference 2024 (JPM24), highlighting its pillars of business.
Archives for January 11, 2024
Ariceum Therapeutics files for UK Clinical Trial Authorisation to test PARP inhibitor for glioblastoma patients
Ariceum Therapeutics, a biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, has submitted an application with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to...
AbbVie’s Produodopa holds potential to become first-choice pump for advanced Parkinson’s
Following the news that AbbVie has launched Produodopa to treat severe motor fluctuations in patients with advanced Parkinson’s disease (PD) in the European Union (EU), Christine Wong, neurology analyst at GlobalData, offers her view: